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Abstract
Background: Only a small amount of research has focused on the relationship between socio-economic status
(SES) and geographic access to prescription medications at community pharmacies in North America and Europe.
To examine the relationship between a community’s socio-economic context and its residents’ geographic access
to common medications in pharmacies, we hypothesized that differences are present in access to pharmacies
across communities with different socio-economic environments, and in availability of commonly prescribed
medications within pharmacies located in communities with different socio-economic status.
Methods: We visited 408 pharmacies located in 168 socio-economically diverse communities to assess the
availability of commonly prescribed medications. We collected the following information at each pharmacy visited:
hours of operation, pharmacy type, in-store medication availability, and the cash price of the 13 most commonly
prescribed medications. We calculated descriptive statistics for the sample and fitted a series of hierarchical linear
models to test our hypothesis that the in-stock availability of medications differs by the socio-economic conditions
of the community. This was accomplished by modeling medication availability in pharmacies on the
socio-economic factors operating at the community level in a socio-economically devise urban area.
Results: Pharmacies in poor communities had significantly higher odds of medications being out of stock, OR=1.24,
95% CI [1.02, 1.52]. There was also a significant difference in density of smaller, independent pharmacies with very
limited stock and hours of operation, and larger, chain pharmacies in poor communities as compared to the middle
and low-poverty communities.
Conclusions: The findings suggest that geographic access to a neighborhood pharmacy, the type of pharmacy,
and availability of commonly prescribed medications varies significantly across communities. In extreme cases,
entire communities could be deemed “medication deserts” because geographic access to pharmacies and the
availability of the most prescribed medications within them were very poor. To our knowledge, this study is first to
report on the relationship between SES and geographic access to medications using small area econometric
analysis techniques. Our findings should be reasonably generalizable to other urban areas in North America and
Europe and suggest that more research is required to better understand the relationship of socio-economic
environments and access to medications to develop strategies to achieve equitable medication access.
Keywords: Community pharmacy, Medication access, Medication desert, Poverty, Socio-economic status, Vehicle
ownership
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Background
The community pharmacy is a critical source of medica-
tions, health services and health information to residents,
[1,2] and pharmacies are especially critical in socio-
economically disadvantaged communities, where access
to prescription medications via online pharmacies and to
health information and resources is often impaired [3].
The term “medication deserts” we introduce in this
paper draws from the concept of food deserts, which is
defined as low availability of nutritious food in under-
served communities. Similarly, the presence of a medica-
tion desert is defined here as the low availability of the
most commonly dispensed prescription medications in
these areas. Little research has focused on the relationship
between the SES of communities and geographic access
to prescription medications at community pharmacies.
The previous studies have raised concerns about the ex-
istence of systematic barriers in the timely procurement
of prescription medications in disadvantaged communi-
ties. This concern is especially relevant because disadvan-
taged communities often have excess morbidity and
mortality from chronic diseases, which require prescrip-
tion medications for disease prevention and management
[3-6].
The barriers to medication and pharmacy access can
be differentiated into two principal groups: economic
and geographic. Economic barriers may prevent indivi-
duals from procuring prescribed medication or adhering
to the provider-prescribed medication regimen due to its
high cost and/or lack of medication coverage.
On the other hand, the geographic location of the
community of residence may affect individual’s economic
or geographic access to medications. Residents that live
in communities without a pharmacy or require lengthy
travel to the closest pharmacy may face geographic bar-
riers to accessing prescription medications regardless of
their economic access. This is the case in rural areas of
the United States (US) where the pharmacy is only
accessible by car. These residents may also be at a dis-
advantage in accessing the range of health services and
health information that the community pharmacies rou-
tinely provide.
Previous studies show that socio-economic factors,
such as lack of health insurance and prescription cover-
age are associated with decreased access to medications,
lower prescription medication use, and higher out-of-
pocket spending [7,8]. In the US, among 92 million
adults with chronic conditions between 2002 and 2004,
over 21% were uninsured for at least 1 month during the
previous year [8]. Rising medication costs worldwide are
occurring alongside increases in medication utilization
due to the surge in chronic diseases [9]. Several studies
aimed to examine the prescription medications dispens-
ing patterns in Europe, United States and Canada and
reported significant differences and reported increases
in both cost and dispensing across countries and demon-
strate that differences exist in access across areas of dif-
ferent socio-economic status [9,10]. Higher prices and
higher dispensing will likely mean greater medication
expenditures for large groups of patients. For example,
increased utilization of angiotensin-converting-enzyme
(ACE) inhibitors, angiotensin receptor blockers (ARBs)
and HMG-CoA reductase inhibitors (commonly referred
to as statins) for cardiovascular disease (CVD) manage-
ment will likely lead to increased costs to patients.
Increasing costs associated with procurement of these
critically-important medications may produce an eco-
nomic barrier to access these medications by patients
[11]. Increased utilization of CVD medications may also
increase their cost short-term, while non-adherence,
procurement and their repercussions will also likely lead
to overall higher costs to the system.
In addition to the economic access to the medications
spatial access needs to be considered. Differences in land
use, transportation networks, population density and
distribution among different regions, such as rural vs
urban areas also influence spatial access to the pharma-
cies and thus to the medications and health information
provided by them. For example, one study showed that
access to Human Immunodeficiency Virus-related retro-
viral medications, information and related health care
services differed significantly for rural and urban resi-
dents [12].
Several contextual variables in communities of residence
may affect access to medications. In many communities,
residents must travel, sometimes for long distances, by
private or public transportation to reach a pharmacy to
procure medications. Therefore, access to transportation,
e.g., a private car, may impact individuals’ ability to pro-
cure medications.
This study examines primarily the quality of health ser-
vices provided by the neighborhood pharmacy (proxied
by the availability of the most community prescribed
medications) and geographic access to the closest phar-
macy (proxied by mean density of pharmacies per neigh-
borhood). From the theoretical perspective, several
approaches have been pioneered to examine the mis-
match between quality of health services and the need of
the population across the SES strata and spatial mis-
match between the need and geographic availability of
various health services and information. The Inverse
Care Law posits that the availability of health resources
varies inversely with need [13]. This approach exploits
the notion that the market model produced stark varia-
tions in quality of health care that physicians are in-
versely related to the need of the populations served.
“Inverse care law operates more completely where med-
ical care is most exposed to market forces, and less so
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where such exposure is reduced” [13]. Some community
pharmacies may not stock commonly prescribed medica-
tions. For example, a recent study demonstrated the
widespread failure of pharmacies located in the poor, pre-
dominately African-American communities to stock opi-
oid analgesics [14].
Geographic perspectives on the issue of accessibility
have mostly centered around the spatial mismatch
hypotheses related to employment. In New York City,
this approach linked residential higher segregation level
to the reduced geographical accessibility to jobs for
African-Americans and other minority inner-city resi-
dents [15]. The mismatch approach to health services
also related the existence of spatial disparities to the mis-
balance between health resources and disadvantaged
population distributions [16]. A recent study linked dis-
parities in geographic access to first-line anti-malarial
medications with the poverty level of the community sur-
rounding the pharmacy [9]. Such barriers in geographic
access may impact medication procurement by the
patients [2].
Even a brief review of salient literature on both topics
reveals that that issues of equity loom large in the spatial
distribution of health services [16-18] and contextual
factors that influence health outcomes such as access to
healthy foods [19-21]. Building on this earlier work, we
consider the existence of pharmacy deserts. It is reason-
able to assume that as with other health services, the
reasons behind pharmacy siting decisions are rooted pri-
marily in market forces and are not based on the need
of the community. If we approach the problem from an
equity perspective, the key question would be where is
the best place to locate a pharmacy to maximize service
to specific populations at highest need?
Several studies have examined the policies and eco-
nomic forces thought to affect procurement of medica-
tions at the local pharmacies [7,22-25]. However, several
key concerns can be raised about this earlier research.
Firstly, these studies focused almost exclusively on eco-
nomic access and did not include geographic access in
the analysis. Yet, geographic access has already been
shown to be an important factor affecting access to
medications and to other health services [22,26-29].
Secondly, these studies were at the national level, and
thus they did not examine the effects of socio-economic
factors on geographic access at the community level.
Yet, given these earlier findings about the key role the
community socio-economic context plays in access to
the health services, it is reasonable to hypothesize that
the community’s socio-economic context may indeed
have an effect on the quality and range of services that
the local pharmacies provide. In particular, these local
socio-economic forces may bear on the complete-
ness of the medication inventory, and thus influence
the residents’ ability to procure their prescription
medications.
In addition to dispensing prescribed medications, the
community pharmacies provide a range of important
health information and services to the local residents
[1,2]. In many areas, pharmacists also administer immu-
nizations and deliver preventative services. For example,
in the US pharmacists routinely administer influenza
and pneumococcal vaccinations and some pharmacies
participate in the Expanded Syringe Access Program
(ESAP) providing non-prescription syringes to help pre-
vent transmission of HIV and of other blood-borne
diseases [1,30]. These activities highlight the import-
ance of the community pharmacy as a key source of
medications, health services and information. Because
of this role, pharmacies are uniquely positioned to im-
prove health outcomes in underserved communities and
access to them is especially critical in disadvantaged
communities, where access to other health resources is
poor [3].
A number of national-level studies have examined
access to medication [7,22-25]. These studies, however,
focused almost exclusively on economic barriers and
did not examine geographic barriers in the analysis, an im-
portant factor affecting access to medications [22,26-29].
These studies were also at the national level, and thus they
did not examine the effects of socio-economic factors on
geographic barriers at the community level. Earlier find-
ings, however, suggest that a community’s socio-economic
context plays a key role in access to medications. If such
community differences in both types of access do indeed
exist, they would suggest inequality in access to medica-
tions and to the range of other health services provided at
the community pharmacy in different areas and thus
should be carefully examined.
Economic conditions in the community and the geo-
graphic access to medications by the local residents may
be related through a number of pathways. In particular,
it is plausible to assume that the local economic condi-
tions in the neighborhood may influence the prevalent
type of pharmacies located there (small independent
stores vs chain outlets), density of pharmacies and which
medications are in kept in stock. The need to develop a
survey methodology to examine relationships of the local
socio-economic conditions on geographic access to the
common prescription medications by the residents and
to analyze them served as the impetus for the current




To examine the relationship between a community’s
socio-economic context and the level of access to
Amstislavski et al. International Journal of Health Geographics 2012, 11:48 Page 3 of 13
http://www.ij-healthgeographics.com/content/11/1/48
common medications and pharmacies by its residents,
we hypothesized that differences are present in:
 geographic access to pharmacies across communities
with different socio-economic environments, and in
 availability and cost of commonly prescribed
medications and health services within pharmacies
located in communities with different socio-
economic status.
We hypothesized that a high poverty in a community
may be inversely related to prescription medication ac-
cess and that such effect on the quality of local pharmacy
service may affect all local residents utilizing the phar-
macy, regardless of their poverty status.
This study was approved by the State University of New
York Downstate Medical Center Institutional Review
Board. Our logic model describes how high community
poverty negatively affects residents’ access to common
prescription medications and the quality of pharmacy
service they receive (see Figure 1). To better understand
such an endogenic effect of the neighborhoods’ socio-
economic environment on availability of medications,
we considered several measures of community socio-
economic status that have been shown to affect access
to health services by its residents. These measures in-
clude neighborhood’s FPL, rate of private vehicle owner-
ship, population density, and pharmacy outlet density.
Community pharmacy mapping
We acquired a list of all active walk-in pharmacies
licensed to practice in New York City from the New
York State, which registers all pharmacies licensed to
operate in the state.
Since we were interested in both geographic access to
pharmacies and availability of commonly prescribed
medications within them, we excluded pharmacies not
readily accessible to the local residents, such as those
located within hospitals and pharmacies that do not
serve walk-in customers (e.g., pharmacies that fill pre-
scriptions over internet only and mail-in order only).
After these ineligible pharmacies were removed, we geo-
coded the remaining pharmacies to their street addresses.
This mapping yielded a total of 2,230 pharmacies using
ArcGIS 10 software (ESRI Redlands, CA). Independent
pharmacies constituted 74% of all eligible pharmacies
and the remaining 26% were corporately or chain-owned
outlets. This represents a significant departure from the
national distribution of the independent vs chain-owned
pharmacies. According to the 2010 data, in the 48 con-
tiguous US states, independently-owned pharmacies
represented 49.37% of all pharmacies (Business Analyst
2010 database, ESRI, Redlands, CA). Pharmacies attached
to a corporate chain store were not excluded from the
sample, and when encountered, labeled as “chain” and
surveyed.
Community demographic socio-economic indicators
The task of defining the appropriate community bound-
aries was important to this study. Selecting large neigh-
borhood units would “smooth” the differences that often
exist in adjacent neighborhoods and selecting small units
would not accurately portray the geographic access to
the pharmacies. While in the US the Census Block Group
is the smallest US Census tabulation area to which
aggregated socio-economic data is available, many block
groups have relatively small populations, and these
block groups and are small in area. Therefore, using
block groups or other similarly small areal units to de-
limit communities would result in a smaller total commu-
nity population denominator, thereby introducing larger
standard error for the SES data. Thus, for the purpose of
this study we opted to use a larger unit to which the SES
data is aggregated, which is U.S. Census 2000 Tracts
(CT) to define the community boundaries [31]. Several
SES indicators which were previously shown to affect
access to a range of health services were computed using
the American Community Survey dataset, including the
percent of population below Federal Poverty Level (FPL),
defined as population with income to the Federal poverty
threshold ratio below 2.00, percentage of households
without a vehicle and population density per square mile
in each community [32]. Additionally, percentage of resi-
dents without health insurance was computed using
health insurance data from the 2011 New York City
Community Health Survey (CHS). Figures 2 and 3 show
the differences in geographic distribution of all pharma-
cies in communities overlaid with percent of residents
in poverty, percentage of the uninsured, and popula-
tion density. Using unique CT identifier numbers, the
community-level SES indicators were later joined to
the pharmacy survey data for sampled communities to
test various hypotheses about relationship between the
community’s socio-economic context and geographic
access to prescription medications by its residents using
regression models.
Survey instrument development and sample selection
We designed a survey tool to assess both the availabil-
ity of prescription medications and the provision of
Figure 1 Logic Model. Logic model of the relationship between
poverty and access to medications.
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pharmacy services. The City of New York is comprised of
five boroughs, namely Brooklyn, the Bronx, Manhattan,
Queens and Staten Island (Figure 4). Each of these large
administrative units is distinctive infrastructurally, demo-
graphically, socio-economically and culturally. Pharmacy
density and population distributions also vary widely
among the boroughs, with Manhattan having the highest
number of pharmacies per capita. We created a database
of all communities (defined as individual CTs) that had
at least one pharmacy present and then randomly
sampled 5% of communities with high, medium, and low
poverty rate respectively, in all boroughs of New York
City except Manhattan. Since Manhattan had only 39 CTs
in the middle poverty group with pharmacies, we modified
our selection schema for that borough by oversampling
Manhattan CTs at the rate of 20%. Random selection at
that rate produced 8 tracts in the “middle poverty” group
in Manhattan. This sampling method yielded a sample of
408 pharmacies in 168 communities in all five boroughs
of New York City.
The survey collected the following information: hours
of operation, pharmacy type (chain or independent), and
the quantity, cash price, and current availability of the
13 most prescribed medications. The 13 prescription
medications included the top 6 brand and 7 generic
medications by total prescriptions written [33]. The
products for which we collected availability and pricing
data and the conditions for which they are prescribed
are listed in the Table 1.
Survey administration
Pharmacy and public health students were trained in
survey administration. The interviewers visited all phar-
macies in the selected 168 communities (See Figure 4).
Surveys were conducted during the daylight hours,
during weekdays, and at various times during the day
according to the schedules of the interviewers. Upon
entry to the store the interviewers introduced them-
selves, showed student identification and explained the
purpose of the visit to the pharmacy staff using a stand-
ard script. The survey-takers asked to speak with the
pharmacist or, if the pharmacist was not available, a
pharmacist technician. The students asked to view a copy
of the pharmacy’s retail drug pricing list. If the pharmacy
declined to participate, the students thanked them for
their time and left the location promptly, taking note for
the pharmacy to be flagged as a “refusal” during data
entry. We only collected data on the pharmacies who
agreed to participate and provided the requested infor-
mation at the time of the visit. The pharmacy participa-
tion rate in the survey was 86.3% (n=352) out of the 408
pharmacies identified and visited. If the pharmacy agreed
Figure 2 Pharmacies and selected SES indicators by community. Maps of all New York City pharmacies overlaid with poverty and percent of
residents without health insurance.
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to provide pricing information for the prescription drugs,
the students used the pricing list to fill in the survey in-
strument, and then searched the shelves for OTC items
to obtain those prices (not reported here). Using the sur-
vey form, the interviewers assessed the availability and
cost of each of the medications on the survey form at
the time of the visit by interviewing the pharmacist on
staff and entered the pharmacist’s responses into the
spreadsheet.
Completed surveys were entered by survey-takers. The
completed database contained pharmacy address infor-
mation, its community’s CT number, coding for income
level, type, hours of operation (whether the outlet is
open Saturday, Sunday, or offers 24 hour service), price
Figure 4 Surveyed pharmacies. Map of surveyed pharmacies located within the sampled communities.
Figure 3 Pharmacies and population density by community. Map of all New York City pharmacies overlaid with population density.
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per container of each item, amount of tablets per con-
tainer, and price per pill information for all 25 products,
and counts of how many items were out of stock. Out of
stock counts were used to create the study’s dependent
variable, defined as the probability of having one or
more prescription items out of stock.
After this pricing data file was complete, one add-
itional data file was created. This file provided descrip-
tive socio-economic data on the sampled communities,
such as chain and independent pharmacy density per
1,000 residents, percent households without car, percent
non-Hispanic black residents, % Hispanic residents, and
median annual household income [32]. Data on these
variables for the surveyed communities in Manhattan
was reported separately (Table 2). A subset of these cen-
sus tract level variables was used in regression analysis
as independent variables describing the neighborhoods’
socioeconomic status to model their hypothesized rela-
tionship with the medication access at the local
pharmacies.
The CT-level estimates from the American Commu-
nity Survey 2005–2009 data were used to create the
study’s independent variables describing the neighbor-
hood socioeconomic status. One limitation of the
American Community Survey data is that it is based on
estimates derived from a sample of the CT's population,
which can introduce large errors when an estimate is
calculated for CTs with small populations. However, this
is the best SES data publicly available in the United
States and in effort to reduce error associated with this
issue we excluded pharmacies with CTs of less than 100
persons from our survey. The aggregated data on health
insurance status in New York City is not available on
the Census Tract level. Therefore, we used insurance
data from the New York City Department of Health and
Mental Hygiene data from the annual Community
Health Survey (CHS) and apportioned it to the census
tracts to utilize in the analysis.
Statistical analysis
After basic descriptive statistics for the sample were cal-
culated, we fitted a series of multilevel models to test
our hypothesis that the in-stock availability of the most
commonly-prescribed medications differs by the socio-
economic conditions of the community. All statistical
analyses were performed with SAS 9.2 software. The key
independent variable of interest was the FPL of the com-
munity. Covariates for this analysis included percentage
of households without a vehicle, community population
density per unit of area, pharmacy density per unit of
population, and percentage of residents without health
insurance. Total pharmacy density, density of the inde-
pendent pharmacies and of the chain pharmacies were
computed per 1,000 residents. Car ownership was com-
puted as a percentage of the households without cars.
We also determined the percentage of the Non-Hispanic
Black residents, Hispanic residents, and the median an-
nual household income in each community. As a proxy
of geographic access to any pharmacy in the neighbor-
hood, we computed pharmacy density per 1,000 resi-
dents in each community by dividing total population
by the total number of pharmacies geocoded in this
community. We used the density of total number of
neighborhood pharmacies per 1,000 residents, and
Table 1 Surveyed medications, their indications, mean price/tablet for each medication and its standard deviation,
minimum and maximum prices in the survey sample







LipitorW (simvastatin calcium) High cholesterol 4.32 0.7 2.1 6.37
NexiumW (esomeprazole magnesium) Acid reflux, gastroesophageal reflux disease (GERD) 7.14 0.91 4.2 13.1
LexaproW (escitalopram oxalate) Depression 4.28 0.51 2.39 6.93
SingulairW (montelukast sodium) Asthma 5.63 0.85 1.93 8.23
ActosW (pioglitazone HCl) Diabetes 9.4 1.15 5.17 13.07
PlavixW (clopidogrel bisulfate) Stroke and heart attack prevention 7.29 1.12 3.77 15
Generic medications
1Hydrocodone-APAP Pain relief 0.62 0.3 0.16 2.67
Lisinopril High blood pressure 0.89 0.36 0.13 1.94
Simvastatin Diabetes 2.35 1.65 0.14 8.37
Levotheroxine Hypothyroidism 0.6 0.31 0.13 2.84
Amoxicillin Bacterial infections 0.61 0.23 0.13 3.16
Metformin Diabetes 0.86 0.62 0.13 2.81
Hydrochlorothiazide Hypertension 0.36 0.14 0.13 1.2
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density of the independent pharmacies and of the chain
pharmacies per 1,000 residents as proxies of geographic
access to any pharmacy, to the independent pharmacies
and to the chain outlets, respectively. We separated inde-
pendent from the chain pharmacies because of their in-
herent differences in the type and scope of services
provided.
Several kinds of generalized mixed linear models were
fitted: Poisson; zero-inflated Poisson; binomial; negative
binomial; and Bernoulli with categories 0 versus > 0
(since 85% of pharmacies had score zero). Models were
compared using the Akaike information criterion.
Polynomials in the predictors were added as necessary
to achieve adequate response functions. The presence of
a random effect associated with community was tested.
Likelihood ratio (LR) methods for estimation of p-values
and confidence intervals (CI) were used. Model residuals
were checked for outliers.
Results
The dependent variable for geographic accessibility of
prescription medications within the community of resi-
dence was the probability of any of the top 13 prescrip-
tion medications in the community pharmacy being out
of stock or otherwise unavailable at the time of the
survey. 85% of the surveyed pharmacies had all 13 pre-
scription medications available. Of the 15% of pharma-
cies that had at least one item out of stock, one item
was missing from 36% of these pharmacies with out-of
stock prescription items. 74.5% of these pharmacies had
five or fewer items missing. The remaining 25.5% had
six or more items missing. The most common occur-
rence in this category was having six items missing, fol-
lowed by all 13 missing. There appeared to be some
spatial clustering of pharmacies with prescriptions out of
stock in Manhattan and in the Bronx, but the number of
pharmacies involved in our sample was too small to
ascribe any statistical significance to this using a cluster
search tool (SatScan, v9.1).
Table 1 provides a list of the 13 surveyed medications,
their indications, mean cash prices per tablet for each
medication and its standard deviation, minimum and
maximum prices in the survey sample.
Table 2 describes the selected socio-economic and
demographic characteristics of the sampled communities
in the five New York City boroughs by the poverty level,
defined as high, medium and low poverty based on the
percentage of households below the 200 percent of
Federal Poverty Level. The data were compared using
ANOVA test; p < 0.05 was considered a statistically
Table 2 Communities characteristics and access to pharmacy by community poverty level
Community characteristics Community federal poverty level (range)
High poverty Medium poverty Low poverty ANOVA
resultTotal number of surveyed communities in outer boroughs(n) 43 67 17
Total pharmacy density per 1,000 residents outer Boroughs
(mean ± SD)
0.51 (± 0.35) 0.62 (± 0.51) 0.35(± 0.17) p=0.0211
Density of independent pharmacies per 1,000 residents except Manhattan
(mean ± SD)
0.39 (± 0.30) 0.40 (± 0.39) 0.13 (± 0.21) 0.0152
Density of chain pharmacies per 1,000 residents except
Manhattan (mean ± SD)
0.06 (± 0.13) 0.22 (± 0.19) 0.17 (± 0.19) p=0.0022
% Households without car (mean ± SD) 75.57 (± 8.02) 51.22 (± 20.17) 30.35 (± 22.55) p<0.0012
% Non-Hispanic Black residents (mean ± SD) 28.98 (± 21.97) 19.09 (± 0.17) 14.76 (± 29.13) p=0.06
% Hispanic residents (mean ± SD) 53.91 (± 22.77) 27.61 (± 23.93) 8.35(± 4.81) p<0.0012
Median Annual Household Income (in US Dollars) 21,419(± 6352) 45,768 (± 16008) 85,177 (± 16265) p<0.001
Total number of surveyed communities in Manhattan (n) 10 7 23
Total pharmacy density per 1,000 residents in Manhattan
(mean ± SD)
0.68 (± 0.37) 0.24 (± 0.10) 0.51 (± 0.38) p=0.0021
Density of independent pharmacies per 1,000 residents in
Manhattan (mean ± SD)
0.43 (± 0.3) 0.21 (± 0.10) 0.10 (± 0.14) p=0.0071
Density of chain pharmacies per 1,000 residents in Manhattan
(mean ± SD)
0.25 (± 0.29) 0.01 (± 0.04) 0.38 (± 0.39) p<.0014
% Households without car (mean ± SD) 77.84 (± 6.15) 78.35 (± 5.05) 72.87 (± 7.35) p=0.068
% Non-Hispanic Black residents (mean ± SD) 32.00 (± 26.95) 34.29 (± 29.81) 1.57 (± 1.16) p=0.0053
% Hispanic residents (mean ± SD) 51.80 (± 31.62) 37.14 (± 20.65) 4.78 (± 1.57) p<0.0011
Median Annual Household Income in Manhattan (in US Dollars) 30,255 (± 11645) 42,182 (± 20408) 11,8358 (± 28982) p<0.0011
1Pairwise comparisons among the means of Communities with all three levels of poverty statistically significant.
2ANOVA was statistically significant and so was pairwise comparison of High vs Medium Poverty Communities.
3ANOVA was statistically significant and so was pairwise comparison of Low vs Medium Poverty Communities.
4ANOVA was statistically significant and so was pairwise comparison of High vs Low Poverty Communities.
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significant difference between the communities surveyed.
The ANOVA p-values highlighted in bold are significant
at p > 0.05 level. Manhattan has very different geo-
graphic, socio-economic and demographic characteristics
compared to the other four New York City Boroughs.
Therefore, we present the descriptive data on Manhattan
separately from the other boroughs.
From Table 2 independent pharmacies are more likely
to be found in the poorer neighborhoods of New York
City (p=0.021) while chain pharmacies are more likely to
be located in lower poverty areas (p=0.01). It is note-
worthy to mention that in some cases the overall
ANOVA result for differences in community character-
istics and access to pharmacy (proxied by pharmacy
density) by the community poverty level was statisti-
cally significant, while the pairwise comparisons among
the means were not (please refer to the table legend).
This is plausibly due to the small sample size in some
of the groups.
Pharmacies open 24 hours were 5% of the respondents
(n=17), these open on Saturday were 91% (n=322), open
on Sunday were 47% (n=166), open both Saturday and
Sunday were 45% (n=159) and closed both Saturday and
Sunday were 7% (n=23).
We were primarily interested in the medications out
of stock in the pharmacies surveyed (Table 3). Over
85.5% of pharmacies reported all the medications sur-
veyed as being in stock. Among the 51 pharmacies
reporting missing medications the most frequent case
was just one medication out o f stock (16 pharmacies),
but the next most frequent case was 5 medications out
of stock.
Regression analysis of survey data
The best-fitting regression model was that associated
with the Bernoulli distribution, with the outcome dichot-
omized as zero vs more than zero. The CT random
effect was of marginal statistical significance (p=0.085),
but the presence or absence of this effect in the model
made very little difference to either estimates or p-values
of the fixed effects; for simplicity, results reported here
do not include the effect. A model containing linear and
quadratic terms in % of households without cars, plus
linear terms in the other predictors satisfied the Hosmer-
Lemeshow lack of fit test (χ28=2.08, p=0.978).
From Table 4, adjusted odds ratio (OR) for a 10
percentage-point increase in population below 200% of
Federal poverty income level for all NYC boroughs was
1.24, with 95% CI [1.02, 1.52]. In other words, for each
10 percentage-point increase in the number of house-
holds in poverty, odds of one or more prescription medi-
cations unavailability on the pharmacy shelves increases
by 24 %, and this increase had a roughly uniform charac-
ter across the range of the data.
Car ownership also was shown to have statistically sig-
nificant effect in the opposite direction. Each percentage-
point increase in the number of the number of households
with a private car in the community was associated with
increased odds of availability of most common prescrip-
tion medications in the local pharmacy.
A LR test of the null hypothesis that both car owner-
ship terms are zero yielded χ22=7.29, p=0.026. ORs for a
1 percentage-point increase in % of households with no
car [95% CI] (estimated at minimum, maximum and
quartile values) were 0.923 [0.866, 0.985] (at min=6.3%),
0.989 [0.964, 1.016] (at Q1=58.3%), 1.005 [0.968, 1.043]
(at Q2=69.8%), 1.017 [0.969, 1.067] (at Q3=78.9%), and
1.035 [0.969, 1.106] (at max=92.5%). Put differently,
the effect of vehicle occurs only in tracts with high
vehicle availability; among such tracts, greater vehicle
unavailability is somewhat associated with reduced
prescription medication unavailability.
Analysis of pharmacies in Manhattan only (N=110)
showed the same general pattern with the same set of
significant predictors (% households without a car had
p=0.013). The OR for % poverty was 1.077, with 95%
CI [1.029, 1.137].
Discussion
The findings of this study demonstrate that geographic
access to a neighborhood pharmacy and the type of
pharmacy (independent versus chain outlet), and to
medications within pharmacies varies significantly across
the communities in a large and socio-economically di-
verse urban area. These findings suggest that a similarly
wide variation in access may exist in urban areas of other
economically developed countries.
While only 14.5% of pharmacies in the sample
reported missing medications and most of these outlets
had multiple medications out of stock (Table 3). This
finding suggests that in some neighborhoods patients
Table 3 Frequencies of pharmacies with the 13 most








0 301 85.51 301 85.51
1 16 4.55 317 90.06
2 5 1.42 322 91.48
3 3 0.85 325 92.33
4 2 0.57 327 92.9
5 11 3.13 338 96.02
6 7 1.99 345 98.01
7 1 0.28 346 98.3
10 1 0.28 347 98.58
13 5 1.42 352 100%
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with several conditions for these medications prescribed
would be able to fill their prescriptions upon the visit to
the pharmacy. This situation could adversely affect
patients with multiple co-morbidities.
As Table 4 shows, there is a significant difference in
density of chain pharmacies in the poorest communities
as compared to the middle- and low-poverty communi-
ties in the outer boroughs. This observation is important
for future initiatives focused on disease prevention and
management. This is because of the different services in-
dependent and chain pharmacies are often able to pro-
vide to the neighborhood. Chain pharmacies typically
have larger facilities and thus may have a wider range of
prescription medications in stock than independent
pharmacies and may be able offer a somewhat broader
range of preventive health services, including vaccina-
tions administered by the pharmacists and self-service
blood pressure monitoring. They are also more likely to
remain open and to have a pharmacist in the store to dis-
perse prescription medication at night, on the weekends
and holidays. Yet, residents of the poorest communities
in the “outer” boroughs of New York City (Brooklyn,
Bronx, Queens, and Staten Island) have the least geo-
graphic access to chain pharmacies at only 0.06 (± 0.13)
pharmacies per 1,000 residents, as compared to the 0.22
(± 0.19) pharmacies per 1,000 residents in the middle
poverty communities. The visual comparison of the ½
mile bandwidth kernel density estimates (KDE) for chain
pharmacies versus independent pharmacies reveal signifi-
cant geographic differences in both geographic distribu-
tion and density of the chain pharmacies in poor and in
outlying parts of the city (see Figure 5).
Fitting the generalized linear models to our data demon-
strated that higher community poverty and lower access
to a private vehicle have a statistically significant associ-
ation with unavailability of the most commonly prescribed
medications. This may have serious consequences in
access to the prescribed medications and a whole range of
other health services by the local residents.
The findings are especially important as poor commu-
nities have the highest prevalence and incidence of
chronic illnesses for which medications are commonly
prescribed [6] and our results suggest that patients in
poor areas, where there is often a higher need for these
medications due to higher disease burden, may experi-
ence greater difficulty in filling their prescriptions.
A potential consequence of disparity in medication
availability in poor areas is that residents have to travel
farther outside of their communities to more affluent
areas with pharmacies stocking their medications. How-
ever, many poor residents are unable, due to lack of
private car and of convenient public transportation, to
travel outside their communities to procure these pre-
scription medications. Even if the local pharmacy is will-
ing to order the out-of-stock medication, the patient will
need to postpone taking it until the needed medication is
delivered. In all of the above scenarios, the care of the
patients living in such “medication deserts” is negatively
affected. While this study did not assess the effect of the
economic and geographic barriers to accessing medica-
tions on medication compliance, it is reasonable to
hypothesize that these barriers directly or indirectly
affect medication compliance and this question needs to
be explored by the future research.
One explanation of the higher odds of common medi-
cations being out-of stock in poorer communities is that
in areas with high poverty and low rates of prescription
insurance coverage, pharmacy operators may decide not
to stock some high-cost prescription medications be-
cause they may not be able to sell them. This explanation
has also been offered by some of pharmacy operators
located in low-income communities with high percentage
of residents without health insurance during our study,
who disclosed that they often charge higher prices for
medications purchased with cash by patients without
health insurance and without prescription coverage.
Clearly, such pricing practices could adversely affect
access to prescription medications for patients without
prescription coverage in low-income area with large
percentage of residents without prescription coverage
and need to be examined in greater depth.
Another question that needs to be examined in the
future research is whether poor geographic access to
medications is associated with reduced prescription
medication compliance in local residents because of the
difficulties procuring it. Published research demonstrates
that high-poverty is linked to higher prevalence and inci-
dence of the very conditions that the medications we
Table 4 Results of multiple predictor generalized linear model (GLM) for all boroughs of New York City
Model parameter Odds ratio for 10%
point increase in odds
of being out of stock
95 % CI for 10 % point increase χ2 (df=1) p-value
% uninsured population 0.8496 0.4579 1.5516 0.28 0.597
% residents in poverty 1.24 1.02 1.52 4.47 0.035
% households without a car 0.414 0.2001 0.8668 5.42 0.020
% households without a car squared 1.01 0.99 1.0141 3.26 0.071
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surveyed are used to treat: asthma, stroke, type 2 diabetes,
hypercholesterolemia, hypertension and heart disease [1].
It would be relevant to further explore the nature of the
relationship between availability of specific groups of
medications in the community pharmacies and the health
outcomes that these medications are used to treat.
Limitations
We used “lack of health insurance” as a proxy to lack of
prescription medication coverage. It is possible that pre-
scription coverage is somewhat independent of health
insurance status and that these benefits would vary
among countries.
Since medications available would vary according to
restocking periods for each pharmacy, and information
on restocking was unavailable to the study team, this is
inevitably a limitation of this study. However, as pharma-
cies were surveyed on different weekdays and at different
times this limitation should not affect generalizability of
our findings. Other potential sources of error were due
to ambiguous labels, errors in correctly recognizing
medication names and quantity of medication units in
packages or containers of different sizes and data entry
errors. An additional limitation of this study is our use of
the number of pharmacies per person in a CT as a proxy
of geographic access to the medications. A more robust
measure of geographic access, such as kernel density esti-
mates, may be a better approach and will be incorporated
into the future steps of this research.
Since this study was focused on access to medica-
tions in the community as experienced by its residents,
we did not consider other avenues of procuring pre-
scription medications, such as via the Internet, at a mail-
in pharmacy or through a health care provider’s office
or clinic. Another limitation of this study is lack of data
on medication procurement at the patient level and
therefore the individual procurement-related behaviors
are unknown. Due to ecological nature of this study,
we did not examine access to the mediations outside
one’s CT of residence. Specifically, our somewhat re-
strictive accessibility focus, defined by the CT of resi-
dence, has a limitation in that it does not examine
the effect of procurement of prescription medications
outside of their communities on the total medication ac-
cess. For example, we did not study how individuals
might draw on pharmacies closer to other anchor loca-
tions in their daily life (near work, along transportation
routes) or procurement by a family member or social
network member.
It is important to understand patient procurement-
related behavior to better leverage the pharmacies’
potential to improve future disease prevention and man-
agement. A better understanding of procurement behav-
ior could bring a much-needed component to this initial
look into the interplay between community poverty and
medication access.
To the best of our knowledge, this study is the first to
report on disparities in access to and availability of com-
mon prescription medications in a large ethnically and
socio-economically diverse urban areas and our methods
should be reasonably generalizable to other large popu-
lation centers in the developed countries.
Figure 5 Kernel density estimates. Kernel density estimates (KDE) of ½ mile bandwidth for chain pharmacies (left image) versus independent
pharmacies (right image).
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Conclusions
To the best of our knowledge, this study is the first to
report on disparities in access to and availability of com-
mon prescription medications in a large ethnically and
socio-economically diverse urban areas and our methods
should be reasonably generalizable to other large popu-
lation centers in the developed countries.
These initial findings suggest that geographic access to
a neighborhood pharmacy, the type of pharmacy, and
in-stock availability of the most commonly prescribed
medications within the pharmacy varies significantly
across communities. In extreme cases, entire communi-
ties could be deemed “medication deserts” because geo-
graphic access to pharmacies and the availability of the
most prescribed medications within them were very
poor. More research is required to better understand the
relationship of socio-economic environments and geo-
graphic access to most common prescription medica-
tions to develop effective strategies to achieve equitable
access to prescription medications in disadvantaged
communities.
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